Lane Keep Assist System & Adaptive Cruise Control Market to be worth US$ 29 Bn by 2025 - TMR
Apr 18, 2018 06:39 am UTC| Business
ALBANY, New York, April 18, 2018 -- Transparency Market Research has released a new market report titled “Lane Keep Assist System and Adaptive Cruise Control Market: (By Component: Electronic Control Unit (ECU) and...
Clinical Trial Management System Market to Generate a Revenue of US$ 3.2 Bn by 2025 - TMR
Apr 18, 2018 06:33 am UTC| Business
Albany, NY, April 18, 2018 -- The global clinical trial management system market was valued at over US$ 1.1 Bn in 2016 and is projected to expand at a cumulative annual growth rate (CAGR) of approximately 13% from 2017...
Canine Stem Cell Therapy Market to Reach US$ 218.2 Mn by 2026 – Persistence Market Research
Apr 18, 2018 06:24 am UTC| Business
New York, April 18, 2018 -- Persistence Market Research (PMR) has published a new research report on canine stem cell therapy. The report has been titled, “Canine Stem Cell Therapy Market: Global Industry Analysis 2016...
Demand for Avocado Oil in North America to Increase in the Coming Years
Apr 18, 2018 06:16 am UTC| Business
Rockville, MD, April 18, 2018 -- Increasing health awareness among people due to prevalence of chronic diseases and heart related disorders owing to improper diet and lifestyle is expected to be a major driving factor...
Global Automotive Elastomers Market Will Reach USD 60.34 Billion by 2023: Zion Market Research
Apr 18, 2018 06:15 am UTC| Business
New York, NY, April 18, 2018 -- Zion Market Research has published a new report titled “Automotive Elastomers Market by Product (thermoplastic polyether block amides, thermoplastic copolyesters, thermoplastic...
Statoil's share saving plan allocates shares
Apr 18, 2018 05:24 am UTC| Business
The shares purchased by DNB on behalf of Statoil ASA (OSE: STL, NYSE: STO) on 13 April 2018 for use in the group's Share Saving Plan have on 18 April 2018 been distributed to the employees in accordance with their savings...
Apr 18, 2018 05:16 am UTC| Business
Basel, Switzerland, April 18, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that its license partner Asahi Kasei Pharma Corporation ("Asahi Kasei Pharma") has started enrollment in a clinical phase 3 study...